Impaired endothelial function in transgenic mice expressing both human renin and human angiotensinogen

Stroke

Volumn 31, Issue 3, 2000, Pages 760-765

  Didion, Sean P ^a   Sigmund, Curt D ^a   Faraci, Frank M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Acetylcholine; Endothelium; Hypertension; Nitric oxide; Nitroprusside

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; ANGIOTENSINOGEN; INDOMETACIN; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PAPAVERINE; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE INHIBITOR; RENIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME MECHANISM; FEMALE; GENE OVEREXPRESSION; HYPERTENSION; INHIBITION KINETICS; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN DISORDER;

EID: 0034056523     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.3.760     Document Type: Article

References (44)

1. Davis SM. Extracranial and intracranial atheroma as causes of stroke. In: Ginsberg MD, Bogousslavsky J, eds. Cerebrovascular Disease: Pathophysiology, Diagnosis, and Management. Vol II. Malden, Mass: Blackwell Science; 1998:1373-1391.
2. Wolf PA, Kannel WB, D'Agostino RB. Epidemiology of stroke. In: Ginsberg MD, Bogousslavsky J, eds. Cerebrovascular Disease: Pathophysiology, Diagnosis, and Management. VoI II. Malden, Mass: Blackwell Science: 1998:834-849.
3. Warlow CP. Epidemiology of stroke. Lancet. 1998;352(suppl III):1-4.
4. Ghiadoni L, Taddei S, Virdis A, Sudano I, Di Legge V, Meola M, Di Venanzio L, Salvetti A. Endothelial function and common carotid artery wall thickening in patients with essential hypertension. Hypertension. 1988;32:25-32.
5. Volpe M, Iaccarino G, Vecchione C, Rizzoni D, Russo R, Rubattu S, Condorelli G, Ganten U, Ganten D, Trimarco B, Lindpainter K. Association and cosegregation of stroke with impaired endothelium-dependent vasorelaxation in stroke prone, spontaneously hypertensive rats. J Clin Invest. 1996;98:256-261.
6. Lezin ES, Simonet L, Pravenec M, Kurtz TW. Hypertensive strains and normotensive "control" strains: how closely are they related? Hypertension. 1992;19:419-424.
7. Merrill DC, Granwehr BP, Davis DR, Sigmund CD. Use of transgenic and gene-targeted mice to model the genetic basis of hypertensive disorders. Proc Assoc Am Physicians. 1997;109:533-546.
8. Merrill DC, Thompson MW, Carney CL, Granwehr BP, Schlager G, Robillard JE, Sigmund CD. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest. 1996;97:1047-1055.
9. Davisson RL, Yang G, Beltz TG, Cassell MD, Johnson AK, Sigmund CD. The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes. Circ Res. 1998;83:1047-1058.
10. 2 in response of cerebral arterioles during chronic hypertension. Am J Physiol. 1992;262: H539-H543.
11. Faraci FM, Sigmund CD, Shesely EG, Maeda N, Heistad DD. Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am J Physiol. 1997;274:H564-H570.
12. Bonthu S, Heistad DD, Chappell DA, Lamping KG, Faraci FM. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. Arterioscler Thromb Vasc Biol. 1997;17:2333-2340.
13. Gunnett CA, Chu Y, Heistad DD, Loihl A, Faraci FM. Vascular effects of LPS in mice deficient in expression of the gene for inducible nitric oxide synthase. Am J Physiol. 1998;275:H416-H421.
14. Lake-Bruse KD, Faraci FM, Shesely EG, Maeda N, Sigmund CD, Heistad DD. Gene transfer of endothelial nitric oxide synthase (eNOS) in eNOS-deficienl mice. Am J Physiol. 1999;277:H770-H776.
15. Paigen B. Genetics of responsiveness to high-fat and high cholesterol diets in the mouse. Am J Clin Nutr. 1995;62:458S-462S.
16. Stewart-Phillios JL, Lough J, Skamene E. Genetically determined susceptibility and resistance to diet-induced atherosclerosis in inbred strains of mice. J Lab Clin Med. 1988;112:36-42.
17. Fujii M, Hara H, Meng M, Vonsattel JP, Huang Z, Moskowitz MA. Strain-related differences in susceptibility to transient forebrain ischemia in SV-129 and C57Black/6 mice. Stroke. 1997;28:1805-1811.
18. Lamping KG, Nuno DW, Chappell DA, Faraci FM. Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice. Am J Physiol. 1999;276:R1023-R1029.
19. 2 in the SHR aorta. Circ Res. 1995;76:1003-1010.
20. Lüscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension. 1986;8:344-348.
21. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
22. Vanhoutte PM. Endothelial dysfunction in hypertension. J Hypertens. 1996;14:S83-S93.
23. Zeiher AM, Drexler B, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest. 1993;92:652-662.
24. Mayhan WG, Faraci FM, Heistad DD. Impairment of endothelium-dependent responses of cerebral arterioles in chronic hypertension. Am J Physiol. 1987;253:H1435-H1440.
25. Mayhan WG, Faraci FM, Heistad DD. Responses of cerebral arterioles to adenosine 5′-diphosphate, serotonin, and the thromboxane analogue U-46619 during chronic hypertension. Hypertension. 1988;12:556-561.
26. Kitazono T, Heistad DD, Faraci FM. Enhanced responses of the basilar artery to activation of endothelin-B receptors in stroke-prone spontaneously hypertensive rats. Hypertension. 1995;25:490-494.
27. Kongo K, Nakagomi T, Kassel NF, Sasaki T, Lehman M, Vollmer DG, Tsukahara T, Ogawa H, Torner J. Effects of aging and hypertension on endothelium-dependent vascular relaxation in rat carotid artery. Stroke. 1988;19:892-897.
28. Lüscher TF, Diederich D, Weber E, Vanhoutte PM, Buhler FR. Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertension. 1988;11:573-578.
29. Van De Voorde J, Vanheel B, Leusen I. Depressed endothelium-dependent relaxation in hypertension: relation to increased blood pressure and reversibility. Pflugers Arch. 1988;411:500-504.
30. White RM, Rivera CO, Davison CB. Differential contribution of endothelial function to vascular reactivity in conduit and resistance arteries from deoxycorticosterone-salt hypertensive rats. Hypertension. 1996;27: 1245-1253.
31. Pinto YM, Buikema H, van Gilst WH, Scholtens E, van Geel PP, de Graeff PA, Wagner J, Paul M. Cardiovascular end-organ damage in Ren-2 transgenic rats compared to spontaneously hypertensive rats. J Mol Med. 1997;75371-75377.
32. Arribas S, Sanchez-Ferrer, Peiro C, Ponte A, Salaices M, Marin J. Functional vascular renin-angiotensin system in hypertensive transgenic rats for the mouse renin gene Ren-2. Gen Pharmacol. 1994;25: 1163-1170.
33. Tschudi MR, Noll G, Arnet U, Novosel D, Ganten D, Lüscher TF. Alterations in coronary artery vascular reactivity of hypertensive Ren-2 transgenic rats. Circulation. 1994;89:2780-2786.
34. Randall MD, March JE. Characterization of endothelium-dependent relaxations in mesenteries from transgenic hypertensive rats. Eur J Pharmacol. 1998;358:31-40.
35. Jacinto SM, Mullins JJ, Mitchell KD. Enhanced renal vascular responsiveness to angiotensin II in hypertensive Ren-2 transgenic rats. Am J Physiol. 1999;276:F315-F322.
36. Webb RC, Vander AJ, Henry JP. Increased vasodilator responses to acetylcholine in psychosocial hypertensive mice. Hypertension. 1987;9: 268-276.
37. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239-242.
38. Pfeifer A, Klau P, Massberg S, Ny L, Sausbier M, Hirneib C, Wang G-X, Korth M, Aszodi A, Andersson K-E, Krombach F, Mayerhofer A, Ruth P, Fassler R, Hofmann F. Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J. 1998;17:3045-3051.
39. Tschudi MR, Mesaros S, Lüscher TF, Malinski T. Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Hypertension. 1996;27:32-35.
40. Cuevas P, Garcia-Calvo M, Carceller F, Reimers D, Zazo M, Cuevas B, Munoz-Willery I, Martinez-Coso V, Lamas S, Gimenez-Gallego G. Correction of hypertension by normalization of endothelial levels of hypertension by normalization of endothelial levels of fibroblast growth factor and nitric oxide synthase in spontaneously hypertensive rats. Proc Natl Acad Sci U S A. 1996;93:11996-12001.
41. Cardillo C, Panza JA. Impaired endothelial regulation of vascular tone in patients with systemic arterial hypertension. Vasc Med. 1998;3:138-144.
42. Taddei S. Endothelium-dependent vasodilation in hypertensive patients. Endothelium. 1996;4:1-9.
43. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993;21:929-933.
44. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension. 1997;29(pt 2):274-279.